PCM
AGN

Peregrine Capital Management’s Allergan plc AGN Stock Holding History

Peregrine Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-59,410
Closed -$12.2M – 256
2017
Q3 		$12.2M Hold
59,410
– – 0.29% 137
2017
Q2 		$14.4M Buy
59,410
+4,966
+9% +$1.17M 0.36% 107
2017
Q1 		$13.1M Sell
54,444
-21,963
-29% -$5.11M 0.33% 111
2016
Q4 		$16M Buy
76,407
+5,182
+7% +$1.07M 0.42% 88
2016
Q3 		$16.4M Buy
+71,225
New +$17.4M 0.43% 88

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Peregrine Capital Management's AGN Position: Q4 2017 in Review

Peregrine Capital Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 59,410 shares — an estimated $12.2M sold.

Peregrine Capital Management first reported a position in AGN in Q3 2016 and held it in 5 quarters. The position peaked at $16.4M in Q3 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Peregrine Capital Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Peregrine Capital Management sold 59,410 Allergan plc shares in Q4 2017, an estimated $12.2M.
  • Peregrine Capital Management first reported a position in Allergan plc in Q3 2016 and held it in 5 quarters.
  • Peregrine Capital Management's Allergan plc position peaked at $16.4M in Q3 2016.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Peregrine Capital Management's 13F filing for Q4 2017, filed 24 Jan 2018.